X0306 4 2021-04-15 0 0001601830 RECURSION PHARMACEUTICALS, INC. RXRX 0001786484 Burrell Terry-Ann C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101 1 0 0 0 Common Stock 2021-04-16 4 A 0 6250 0.00 A 126561 D Stock Option (Right to Buy) 18.00 2021-04-15 4 A 0 12500 0.00 A 2031-04-14 Common Stock 12500 12500 D Stock Option (Right to Buy) 2.22 2030-04-28 Common Stock 404688 404688 D Immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, each share of Common Stock shall be reclassified into one share of Class A Common Stock. The shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of common stock of the Issuer, with all such shares being received on the earlier of April 16, 2022 or the Issuer's first annual meeting of stockholders. The option becomes exercisable upon the earlier of April 15, 2022 or the date of the Issuer's first annual meeting of stockholders. One forty-eighth (1/48th) of the shares subject to the award shall vest one month after April 29, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date. /s/ Nathan Hatfield, attorney-in-fact 2021-04-19